Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry R Smith

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Vaccine|May 20, 2008
Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responsesShakuntala Megati, Dorys Garcia-Hand, Sarah Cappello, et al.
Vaccine|February 2, 2010
Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutininLarry R Smith, Mary K Wloch, Ming Ye, et al.
Eclinicalmedicine|April 12, 2021
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipientsPer Ljungman, Arancha Bermudez, Aaron C Logan, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Vaccine|May 20, 2008
Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responsesShakuntala Megati, Dorys Garcia-Hand, Sarah Cappello, et al.
Vaccine|February 2, 2010
Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutininLarry R Smith, Mary K Wloch, Ming Ye, et al.
Eclinicalmedicine|April 12, 2021
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipientsPer Ljungman, Arancha Bermudez, Aaron C Logan, et al.
Pageof 3